KNSA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Kiniksa Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 63.95 USD 2.47%

Market Cap: $4.9B

	Kiniksa Pharmaceuticals Ltd NASDAQ:KNSA	BM
I	Intuitive Surgical Inc XMUN:IUI1	US
I	Industrial and Commercial Bank of China Ltd XBER:ICK	CN
C	Casella Waste Systems Inc F:WA3	US
	Capricor Therapeutics Inc F:4LN2	US
A	Albemarle Corp SWB:AMC	US
C	Cashbuild Ltd XBER:C8J	ZA
F	Frontline Ltd NYSE:FRO	BM

Profitability Summary

Kiniksa Pharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

89%

Strong 3Y Average Gross Margin

87%

Declining Gross Margin

90% > 89%

Healthy Operating Margin

12%

Negative 3Y Average Operating Margin

-1%

Declining Operating Margin

14% > 12%

Low Net Margin

10%

Low 3Y Average Net Margin

Declining Net Margin

82% > 10%

Exceptional Free Cash Flow Margin

22%

Strong 3Y Average Free Cash Flow Margin

10%

Free Cash Flow Margin is Increasing

Positive 3Y Average ROIC

10%

Declining ROIC

111% > 19%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.